About Us

Journal History

Molecular Imaging and Radionuclide Therapy, the official publication of Turkish Society of Nuclear Medicine (TSNM), and the continuation of former Turkish Journal of Nuclear Medicine, was started publishing in 2011.

Previous Title: Turkish Journal of Nuclear Medicine

E-ISSN: 2147-1959

Title: Molecular Imaging and Radionuclide Therapy

Official Abbreviation: Mol Imaging Radionucl Ther

Free-of-Charge Publication

No fee is charged from the authors during the submission, evaluation and publication process. Journal practices, ethical rules, technical information and necessary forms are specified on the journal's web page.

The manuscripts must be submitted via the Journal Agent online article system, represented on the journal website.

Abstracting and Indexing

BASE - Bielefeld Academic Searching EngineCNKIAGORAARDIOAREGOALIHinariİdealOnlineTürk MedlineTurkiye Citation IndexJ-GateGALEProQuestEMBASEEBSCOTübitak Ulakbim TR IndexSCOPUSIndex Medicus/PubMedPubMed Central (PMC)PubMed/MEDLINEWeb of Science Emerging Sources Citation Index (ESCI)

Digital Archiving and Preservation Policy

Digital preservation is a set of processes and activities that ensure the retrieval and distribution of information now available in digital formats to guarantee long-term, perpetual access. The preservation policy includes the following measures:

Website Archiving

All of the electronic content (website, manuscript, etc.) is stored in three different sources. Content on a server is online and accessible to readers. A copy of the same content is preserved as a backup on other servers. Should a server fail, other resources can be brought online, and the website is expected to be available in 24-36 hours.

Abstracting/Indexing Services

Our journal's Abstracting/Indexing services store essential information about articles. In addition, some of our journals’ Abstracting/Indexing services archive metadata about the article and electronic versions of the articles. In this way, copies of articles are presented to the scientific community through these systems as an alternative to journals.

Author Self-Archiving Policy

Authors are permitted and encouraged to post their articles on personal and institutional websites after publication (while providing full bibliographic details and a link to the original publication).

Written permission from the publisher is required for commercial use of the content.

Sustainable Development Goals

We are proud to announce that Molecular Imaging and Radionuclide Therapy has signed the Sustainable Development Goals for Publishers, a commitment by the publishing community to contribute towards achieving the United Nation's Sustainable Development Goals. As a responsible journal, we recognize the importance of addressing global challenges and promoting sustainable development.

Through our participation in the SDG Publisher Compact, we reaffirm our dedication to making a positive impact on society. We are committed to supporting three specific SDGs: Goal 3 - Good Health and Well-being, Goal 4 - Quality Education, and Goal 9 - Industry, Innovation, and Infrastructure.

By aligning our efforts with these goals, we aim to foster advancements in healthcare, education, and technology. We believe that by publishing high-quality research and knowledge in these areas, we can contribute to creating a better and more sustainable world.

For more information about the SDGs and our commitment to sustainable development, please feel free to contact us or visit the United Nation's Sustainable Development Goal’s website.